Seminars in Hematology
Volume 47, Issue 2 , Pages 133-142, April 2010

Rituximab in Indolent Lymphomas

James P. Wilmot Cancer Center, and Department of Medicine, University of Rochester, Rochester, NY

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 J.F. is a Scholar in Clinical Research of the Leukemia & Lymphoma Society, and is supported in part by the University of Rochester SPORE in Lymphoma (1P50CA130805).

PII: S0037-1963(10)00004-1

doi:10.1053/j.seminhematol.2010.01.003

Seminars in Hematology
Volume 47, Issue 2 , Pages 133-142, April 2010

Article Tools

* Image Usage & Resolution